Evidence map›Paper›PMID 41065539›Full record

ArticleEuropean journal of heart failure2025

The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient.

Haruyuki Kinoshita, Hiroshi Sugino, Masashi Kodama, Misato Saito, Yoji Sumimoto, Kenji Masada, Takashi Shimonaga, Akiyo Suga, Mayumi Toko, Kaori Taniyasu and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Haruyuki KinoshitaDepartment of Cardiology, NHO Kure Medical Center, Kure, Japan.ORCID https://orcid.org/0000-0002-0831-9230
Hiroshi SuginoDepartment of Cardiology, NHO Kure Medical Center, Kure, Japan.
Masashi KodamaDepartment of Cardiology, NHO Kure Medical Center, Kure, Japan.
Misato SaitoDepartment of Cardiology, NHO Kure Medical Center, Kure, Japan.
Yoji SumimotoDepartment of Cardiology, NHO Kure Medical Center, Kure, Japan.
Kenji MasadaDepartment of Cardiology, NHO Kure Medical Center, Kure, Japan.
Takashi ShimonagaDepartment of Cardiology, NHO Kure Medical Center, Kure, Japan.
Akiyo SugaThe Ultrasound Team, Physiological Examination Department, NHO Kure Medical Center, Kure, Japan.
Mayumi TokoThe Ultrasound Team, Physiological Examination Department, NHO Kure Medical Center, Kure, Japan.
Kaori TaniyasuThe Ultrasound Team, Physiological Examination Department, NHO Kure Medical Center, Kure, Japan.
Saki UshirozakoThe Ultrasound Team, Physiological Examination Department, NHO Kure Medical Center, Kure, Japan.
Yumiko KatayamaThe Ultrasound Team, Physiological Examination Department, NHO Kure Medical Center, Kure, Japan.
Chiemi HiraharaThe Ultrasound Team, Physiological Examination Department, NHO Kure Medical Center, Kure, Japan.
Masahiro TakadaDepartment of Pharmacy, NHO Kure Medical Center, Kure, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41065539
PMCPMC12803529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.